|
|
|
|
| LEADER |
03519nam a22003373i 4500 |
| 001 |
EBC31498659 |
| 003 |
MiAaPQ |
| 005 |
20240729202206.0 |
| 006 |
m o d | |
| 007 |
cr cnu|||||||| |
| 008 |
240729s2020 xx o ||||0 eng d |
| 020 |
|
|
|a 9789240006638
|q (electronic bk.)
|
| 035 |
|
|
|a (MiAaPQ)EBC31498659
|
| 035 |
|
|
|a (Au-PeEL)EBL31498659
|
| 040 |
|
|
|a MiAaPQ
|b eng
|e rda
|e pn
|c MiAaPQ
|d MiAaPQ
|
| 245 |
1 |
0 |
|a Report of the Third Meeting of the WHO Onchocerciasis Technical Advisory Subgroup, Geneva, Switzerland, 26-28 February 2019.
|
| 250 |
|
|
|a 1st ed.
|
| 264 |
|
1 |
|a Geneva :
|b World Health Organization,
|c 2020.
|
| 264 |
|
4 |
|c Ã2020.
|
| 300 |
|
|
|a 1 online resource (49 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 505 |
0 |
|
|a Intro -- Recommendations -- 1. Exclusion mapping (i.e. identification of unmapped areas where the environment is unfavourable for the presence of black flies) is important and should be undertaken before proceeding to stage 1 mapping. -- 1. Introduction -- 2. Opening session -- 2.1 Summary of the second meeting -- 2.2 Review of serological tests -- 3. Country presentations -- 3.1 Mali: nearing stop MDA -- 3.2 United Republic of Tanzania: nearing stop MDA -- 3.3 Togo: nearing stop MDA -- 3.4 Malawi: elimination mapping and nearing stop MDA studies -- 3.5 Nigeria: mapping plus a question of thresholds -- 3.6 Ghana: mapping -- 3.7 Kenya: mapping -- 3.8 Ethiopia: a question of thresholds -- 3.9 Burundi: mapping -- 4. Comparison of ELISA platforms and RDT -- 4.1 ELISA verification phase and QA for serological tests -- 4.2 ELISA standardization -- 4.3 Efforts to improve RDT: using DBS with RDT -- 4.4 Efforts to improve RDT: dual antigen onchocerciasis test strip -- 4.5 Dual antigen test strip: additional data -- 4.6 Summary of RDT versus ELISA comparison -- 4.7 Diagnostics summary -- 4.8 Discussion on ELISA and RDT -- 4.9 Recommendations on ELISA and RDT -- 5. Onchocerciasis elimination mapping -- 5.1 Identification of first-line villages -- 5.2 Sampling methods for stage 1 mapping -- 5.3 Lessons from the field on stage 1 mapping -- 5.4 Sampling methods for stage 2 mapping -- 5.5 Experience with stage 2 mapping -- 5.6 Additional lessons from pilot surveys of stage 1 and 2 mapping -- 5.7 Onchocerciasis mapping in areas co-endemic for LF -- 5.8 Recommendations on onchocerciasis elimination mapping -- 1. Exclusion mapping (or identification of unmapped areas where the environmental is unfavourable for the presence of black flies) is important and should be undertaken before proceeding to stage 1 mapping. -- 6. Maximizing the available diagnostic tools.
|
| 505 |
8 |
|
|a 7. Updates -- 7.1 Stop MDA threshold -- 7.2 New diagnostics -- 7.3 Milestones for elimination: developing the road map to 2030 -- 7.4 Pre-stop MDA assessments.
|
| 588 |
|
|
|a Description based on publisher supplied metadata and other sources.
|
| 590 |
|
|
|a Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.
|
| 655 |
|
4 |
|a Electronic books.
|
| 776 |
0 |
8 |
|i Print version:
|t Report of the Third Meeting of the WHO Onchocerciasis Technical Advisory Subgroup, Geneva, Switzerland, 26-28 February 2019
|d Geneva : World Health Organization,c2020
|
| 797 |
2 |
|
|a ProQuest (Firm)
|
| 856 |
4 |
0 |
|u https://ebookcentral.proquest.com/lib/matrademy/detail.action?docID=31498659
|z Click to View
|
